Protea Biosciences
Protea, Mass General Partner on Cancer Immunotherapy Tests
The partners aim to develop a diagnostic methodology for obtaining cancer cell molecular profiles to help guide immunotherapies.
Protea, Proteos Form Comarketing Partnership
The companies will market Proteos' protein production services alongside Protea's bioanalytical services.
In Brief This Week: Ambry Genetics, DNAstack, Protea Biosciences, and More
This week's news includes Ambry Genetics, DNAstack, Protea Biosciences Group, Exosome Diagnostics, BGI Europe, and Castle Biosciences.
The mass spectrometry services and instrument firm is working with a Yale pathologist to develop proteomic tests for solid tumors.
Protea, Yale Ink License Agreement for Melanoma Test
The test using proteomic mass spectrometry imaging to separate cancerous spots from benign moles was developed jointly by scientists at Protea and Yale.
Apr 7, 2015
Protea to Acquire VivoPharm for $11.2M
Apr 11, 2014
Apr 5, 2013
Feb 8, 2013
Feb 8, 2013
Oct 26, 2012
Mar 12, 2012
Waters, Protea Ink Co-marketing Pact
Oct 14, 2011
Movers & Shakers: Oct 14, 2011
Premium
Oct 7, 2011
New Products: Oct 7, 2011
Premium
Sep 23, 2011